Title : Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

Pub. Date : 2015 Mar

PMID : 25546031






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: In patients suffering multiple sclerosis activity despite treatment with interferon beta or glatiramer acetate, clinicians often switch therapy to either natalizumab or fingolimod. Fingolimod Hydrochloride interferon beta 1 Homo sapiens